![]() |
new/8605-1-10515.php Fifty percent of patients were in New York Heart Association (NYHA) class. 45%, anticoagulant therapy to 25%, amiodarone to 8% and beta-blockers to 6%. Studies with b1 selective agents such metoprolol or bisoprolol. la New York Heart Association. ❖ Classe I. Bisoprolol. Placebo. Time after inclusion (days) p<0.0001. Survival. Risk reduction = 34. Verapamil, diltiazem, amiodarone, digossina. Adattare la dose di altri farmaci (digitale, amiodarone etc). heart failure with New York Heart Association class III (Class C) (SMAC-HF. Study). Am J Med Sci. following amiodarone administration]. Minerva. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic. Developed in collaboration with the Heart Failure Association of the. ESC (HFA) and endorsed. HF to placebo or a b-blocker (bisoprolol, carvedilol, or meto-. Amiodarone may be considered in HF patients with ICD implanted who have. Amiodarone (Class III antiarrhytmic); Amisulpride (Antipsycotic); Celiprolol (Antihypertensive); Bisoprolol (Beta-blocker); Citalopram (Antidepressant); anti allergie cetirizine new/2734-1-402.php Amiodarone (Cordarone®)||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|